Načítá se...
Future of Cholesterol Ester Transfer Protein (CETP) inhibitors: A Pharmacological Perspective
In almost 30 years since the introduction of HMG-CoA reductase inhibitors (statins), no other class of lipid modulators has entered the market. Elevation of high-density lipoprotein-cholesterol (HDL-C) via inhibiting cholesteryl ester transfer protein (CETP) is an attractive strategy for reducing th...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3720705/ https://ncbi.nlm.nih.gov/pubmed/23658137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-013-0071-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|